Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout.

Saved in:
Bibliographic Details
Title: Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout.
Authors: Lipsky PE, Calabrese LH, Kavanaugh A, Sundy JS, Wright D, Wolfson M, Becker MA
Source: Arthritis research & therapy [Arthritis Res Ther] 2014 Mar 04; Vol. 16 (2), pp. R60. Date of Electronic Publication: 2014 Mar 04.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101154438 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-6362 (Electronic) Linking ISSN: 14786354 NLM ISO Abbreviation: Arthritis Res Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1478-6362
DOI:10.1186/ar4497